Endocrine Abstracts

Objective: This open-label, single-arm study assessed the long-term safety and efficacy of injectable testosterone undecanoate (TU; Nebido) in men with hypogonadism.Methods: Men aged 18–75 years with hypogonadism (baseline serum total testosterone <10 nmol/l) were recruited. The study was performed under conditions designed to resemble routine clinical management: patients with underlying conditions such as diabetes mellitus and hypertension wer...